Cargando…

Mcl-1 stabilization confers resistance to taxol in human gastric cancer

Taxol has been extensively used as an antineoplastic drug to treat human gastric cancer. However, the acquired drug resistance invariably develops and greatly limits the therapeutic efficacy of Taxol. Identification of the underlying resistance mechanisms may inform the development of new therapies...

Descripción completa

Detalles Bibliográficos
Autores principales: Shuang, Wu, Hou, Lili, Zhu, Yan, Li, Qun, Hu, Wanglai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5669943/
https://www.ncbi.nlm.nih.gov/pubmed/29137317
http://dx.doi.org/10.18632/oncotarget.20222

Ejemplares similares